Claudin-1 Is a Therapeutic Target for Crescentic Glomerulonephritis

Geoffrey Teixeira; Jean‐Daniel Delbet; Vincent Anquetil; Alberto Toso; Stephen Toovey; Luigi Manenti; Roberto Iacone; Jesper Kers; Ton J. Rabelink; Kevin Saitoski; Thomas F. Baumert; Ariela Benigni; Susanna Tomasoni; Giuseppe Remuzzi; Thomas Cagarelli; Marco Prunotto; Solange Moll; Pierre‐Louis Tharaux

doi:10.1681/asn.20233411s1238c

Related publications

Article2003

Plasminogen Activator Inhibitor-1 Is a Significant Determinant of Renal Injury in Experimental Crescentic Glomerulonephritis

A. Richard Kitching, Yao Kong, Xiao Ru Huang, Piers Davenport, Kristy L. Edgtton, Peter Carmeliet, Stephen R. Holdsworth, Peter G. Tipping

Article2005

IL-12p40 and IL-18 in Crescentic Glomerulonephritis

A. Richard Kitching, Amanda Turner, Gabrielle R. Wilson, Timothy Semple, Dragana Odobasic, Jennifer R. Timoshanko, Kim M. O’Sullivan, Peter G. Tipping, Kiyoshi Takeda, Akira Shizuo, Stephen R. Holdsworth

Journal of the American Society of Nephrology

Letter2004

Is 11β-hydroxysteroid dehydrogenase type 1 a good therapeutic target for blockade of glucocorticoid actions?

George Chrousos

Article2013

PLACENTAL GROWTH FACTOR/NEUROPILIN 1 SIGNALING IS A THERAPEUTIC TARGET IN PEDIATRIC MEDULLOBLASTOMA

Matija Snuderl, Ana Batista, Nathaniel D. Kirkpatrick, Carmen Ruiz de Almodóvar, Lars Riedemann, Ellen Knevels, Thomas Schmidt, Teresa Peterson, Sylvie Roberge, Carlos Bais, Stephen Yip, Martin Hasselblatt, Claudia Rössig, Napoleone Ferrara, Michael Klagsbrun, Dan G. Duda, Dai Fukumura, Lei Xu, Peter Carmeliet, Rakesh K. Jain

Article2005

Is Regression of Chronic Nephropathies a Therapeutic Target?

Giuseppe Remuzzi, Andrea Remuzzi